FDA Inspection 1192948 — Alexander E. Horwitz, III, M.D.
The FDA completed an inspection of Alexander E. Horwitz, III, M.D. on October 28, 2022 in Spokane, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 28, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Spokane, WA (United States)
Additional Details
Clinical Investigator (CI)